UM Researchers Connect Specific Protein To Head, Neck Cancers
Watch CBS News
The issue of U.S. nuclear safety has come into focus following the Japan quake.
Beaumont Hospital Royal Oak announced two major advances in cancer treatment Thursday -- minimally invasive surgery for esophageal cancer and microwave ablation to treat inoperable tumors.
Ann Arbor-based NextGen Sciences Inc., a subsidiary of London, England-based NextGen Group plc, Wednesday announced a reorganization and several new staff positions.
Livonia's Stevenson High School is mourning the death of one of its students.
A Wayne State University School of Medicine physician-researcher has developed a personalized therapy to treat a wide range of cancers.
A rare form of cancer has sidelined Dave Ritter, who owns Dave's Barber Shop in Birmingham: a benefit is scheduled for March 13.
The majority of people from a genetic study opted to be told whether they carried a cancer-causing gene mutation, and the knowledge did not cause emotional distress or change their health behaviors, a new study from the University of Michigan shows.
A Roseville woman accused of faking her son's cancer will stand trial.
The Queen of Soul is talking about her recent health problems -- but not revealing too much.
It has not yet been decided if a Roseville mother accused of raising thousands of dollars by faking her son's illness will stand trial.
Boston scientists who invented the test and health care giant Johnson & Johnson will announce Monday that they are joining forces to bring it to market.
Following surgey for an undisclosed ailment, Detroit songstress Aretha Franklin is back at home in time for the holidays.
A hearing for a Roseville woman accused of faking her son's cancer has been postponed until next month.
The risk of esophageal cancer among patients who suffer from gastroesophageal reflux disease is not as high as many may think, according to new research from University of Michigan gastroenterologists.
A new report says the Queen of Soul Aretha Franklin is suffering from pancreatic cancer.
Health regulators said Monday that two drugs from GlaxoSmithKline and Merck reduce the risk of prostate cancer in men, though scientists questioned the drugs' overall benefit, since the tumors they prevent are usually not life-threatening.
